Resection for Multiple Hepatocellular Carcinomas (HCC)
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Transarterial RAdioembolization Versus ChemoEmbolization for the Treatment of Hepatocellular Carcinoma (HCC)
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy of RAD001 + TACE in Localized Unresectable HCC
- Status
- TERMINATED
- Phase
- PHASE2
Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
TRC105 for Liver Cancer That Has Not Responded to Sorafenib
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Sirolimus In Liver Transplantation for Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE2
AFP- L3% and DCP as Tumor Markers in Patients With Hepatocellular Carcinoma (HCC) Treated With Transarterial Chemoembolisation (TACE)
- Status
- COMPLETED
- Phase
- N/A
Palliative Treatment of Hepatocellular Carcinoma in Patient With CHILD B Cirrhosis
- Status
- COMPLETED
- Phase
- PHASE2
Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +Axitinib
- Status
- COMPLETED
- Phase
- PHASE2
Radiofrequency Ablation Versus Hepatic Resection for the Treatment of Hepatocellular Carcinomas Smaller Than 2 cm
- Status
- UNKNOWN
- Phase
- PHASE4
TheraSphere for the Treatment of Unresectable Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1
Stereotactic Body Radiotherapy for Liver Tumors
- Status
- COMPLETED
- Phase
- NA
Stiffness Measurement of Liver Tumors and Visceral Parenchyma
- Status
- UNKNOWN
- Phase
- N/A
Evaluation of Cirrhosis and Malignant Hepatic Lesions Using Novel MR Contrast Agents
- Status
- UNKNOWN
- Phase
- N/A
Effectiveness of Microwave Ablation of Hepatocellular Carcinoma as Compared to Radiofrequency Ablation
- Status
- COMPLETED
- Phase
- NA
Temsirolimus + Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Study of Axitinib in Patients With Unresectable Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Drug-eluting Bead in Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE4
Study of Combined Sorafenib With Radiotherapy in Patients With Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A